Summary of the technology
We are licensing our anti-staphylococci herbal mix extract (patent pending) with a great safety profile for veterinary use as anti-pyoderma spray (or other formulation). Successful animal model results are available. Available as API or finished product ( in preparation, Q2/2018 ).
Desired business relationship
Veterinary Hygiene Product
Current development status
Commercially available technologies
Intellectual property status
Patent already applied for
Small and Medium Enterprise
Small and Medium Enterprise from FranceAlphanosos
Alphanosos is a privately held company incorporated November 2014 in France. We are leveraging our disruptive, AI based, proprietary discovery process to discover and patent active ingredients and products based on plants with a history of safe human consumption to replace, with a superior efficacy and reduced risks of side effects, many of the chemical products used as therapeutic drugs in the human and animal health industries. We concentrate our discovery efforts on the selective killing of deleterious micro-organisms and cells. Our initial focus is on new antibiotics and anti-cancer products, with first products already in post-discovery phase and a first patent application on anti-staphylococci products, for which we already obtained topical and systemic animal model results. Early revenue is already generated by licenses for cosmetic usage of certain of these products, to be soon followed with licenses for veterinary applications and later for human drugs.